Clinicians may have difficulty in making a diagnosis. Various macular dystrophies can resemble AMD due to the variety of clinical signs and symptoms. Clinicians may find it challenging to ...
What to take away on PBM, hormonal eye health, and GLP-1 receptor agonists from this year’s meeting.
The FDA approved Lucamzi (ranibizumab-blrz; Xbrane Biopharma), a biosimilar to Lucentis (ranibizumab; Genentech), for neovascular (wet) age-related macular degeneration (AMD) and ...
This week’s top stories include pipeline updates in dry eye, retinitis pigmentosa, contact lens hygiene, and more.
Under the terms of the agreement, Iolyx Therapeutics has granted Théa exclusive worldwide development and commercialization rights, excluding Asia, to ILYX-002 for the treatment of ocular surface ...
The meeting, which comes a year after the agency issued a complete response letter in October 2025,2 was held from 8:30 am-3 ...
Raphael Rostenne discusses what a good phone call looks like and contributes to successful patient interactions with host ...
Amanda Nanasy, OD, discussed how sports can open the door to eye care for underserved athletes and what goes into her performance vision evaluations. In an exclusive interview with Optometry Times, ...
FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites. The FDA granted ...
Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.
Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results